Outlook Therapeutics, Inc.
10-K December 19, 2025
Key Highlights
- This year was critical for pushing ONS-5010 towards FDA approval, which is the s...
- Outlook Therapeutics is heavily invested in getting ONS-5010 approved for wet AM...
Read Analysis
🤖 AI Generated